Sonia Reyes Podcasts, Healthcare Headlines, Breast Cancer, Population Health Management | Jul 20, 2026 Dr. Eleonora Teplinsky discusses research emerging from the ASCO 2026 Annual Meeting on GLP-1 use and Breast Cancer prevention, and what questions remain before they can be considered part of a cancer prevention strategy.
George Padron Oncology Care, Healthcare Headlines, Access & Affordability | Jul 3, 2026 A nationwide shortage of generic chemotherapy drugs including cisplatin and ifosfamide is forcing oncology practices toward rationing and dose-spacing.
George Padron Oncology Care, Healthcare Headlines | Jun 30, 2026 A Lancet editorial reports rising early-onset cancer across 42 countries and warns that health systems are underprepared to detect and coordinate care
Sonia Reyes Oncology Care, Podcasts, Healthcare Headlines, Breast Cancer, Endocrinology & Metabolic | Jun 29, 2026 Dr. Denise Yardley of SCRI interpreted observational data presented at ASCO 2026, indicating that breast cancer patients on GLP-1 medications may progress to metastatic disease at approximately half the rate of those on older diabetes treatments.
George Padron Oncology Care, Biomarker & Genomic Testing, GU Cancers | Jun 20, 2026 An updated Cochrane review of almost 800,000 men finds PSA screening likely reduces prostate cancer deaths, about one per 500 invited, set against overdiagnosis risk.
George Padron Oncology Care, Managed Care, Value Based Care | Jun 19, 2026 Dana-Farber's PATH-SIC trial: pre-visit nudges to oncologists and patients lifted documented care-goal conversations 79%, yet only a third occurred.
🔎︎
